CN1938309B - Crf受体拮抗剂及其相关方法 - Google Patents
Crf受体拮抗剂及其相关方法 Download PDFInfo
- Publication number
- CN1938309B CN1938309B CN2004800420125A CN200480042012A CN1938309B CN 1938309 B CN1938309 B CN 1938309B CN 2004800420125 A CN2004800420125 A CN 2004800420125A CN 200480042012 A CN200480042012 A CN 200480042012A CN 1938309 B CN1938309 B CN 1938309B
- Authority
- CN
- China
- Prior art keywords
- compound
- mixture
- crf
- alkyl
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 Cc([n]1nc2*)cc(C)nc1c2-c1c(*)cc(*)cc1* Chemical compound Cc([n]1nc2*)cc(C)nc1c2-c1c(*)cc(*)cc1* 0.000 description 2
- LMZFRYNNKPIKSM-UHFFFAOYSA-N Cc1n[n]2c(CO)cc(C)nc2c1-c(c(OC)c1)ccc1-[n]1nccc1 Chemical compound Cc1n[n]2c(CO)cc(C)nc2c1-c(c(OC)c1)ccc1-[n]1nccc1 LMZFRYNNKPIKSM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
化合物 | R2 | MW | MS | tR * |
5-1 | -C(O)N(CH3)2 | 390.44 | 5.17 | |
5-2 | -C(O)N(CH2CH3)2 | 418.50 | 419.2 | 6.22 |
5-3 | -C(O)N(CH3)CH2CH3 | 404.47 | 405.2 | 5.66 |
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53203103P | 2003-12-22 | 2003-12-22 | |
US60/532,031 | 2003-12-22 | ||
PCT/IB2004/004234 WO2005063755A1 (en) | 2003-12-22 | 2004-12-20 | Crf receptor antagonists and methods relating thereto |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1938309A CN1938309A (zh) | 2007-03-28 |
CN1938309B true CN1938309B (zh) | 2011-11-09 |
Family
ID=34738733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800420125A Expired - Fee Related CN1938309B (zh) | 2003-12-22 | 2004-12-20 | Crf受体拮抗剂及其相关方法 |
Country Status (19)
Country | Link |
---|---|
US (1) | US7737154B2 (zh) |
EP (1) | EP1697374B1 (zh) |
JP (1) | JP4926720B2 (zh) |
KR (1) | KR20070009537A (zh) |
CN (1) | CN1938309B (zh) |
AR (1) | AR046967A1 (zh) |
AU (1) | AU2004309168B2 (zh) |
BR (1) | BRPI0417943A (zh) |
CA (1) | CA2550948A1 (zh) |
IL (1) | IL176350A0 (zh) |
IS (1) | IS8526A (zh) |
MA (1) | MA29984B1 (zh) |
MY (1) | MY143499A (zh) |
NO (1) | NO20063230L (zh) |
NZ (1) | NZ547990A (zh) |
RU (1) | RU2394035C2 (zh) |
TW (1) | TW200530242A (zh) |
WO (1) | WO2005063755A1 (zh) |
ZA (1) | ZA200604574B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
US8815599B2 (en) | 2004-06-01 | 2014-08-26 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
EP1802621B1 (en) * | 2004-10-19 | 2009-05-06 | SmithKline Beecham (Cork) Limited | Crf receptor antagonists and methods relating thereto |
GB0519957D0 (en) * | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
US8088779B2 (en) * | 2005-09-30 | 2012-01-03 | Smithkline Beecham (Cork) Limited | Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
MX2009003098A (es) * | 2006-09-20 | 2009-04-01 | Lilly Co Eli | Compuestos de tiofen pirazolopirimidina. |
MX2009003125A (es) * | 2006-09-20 | 2009-05-28 | Lilly Co Eli | Tiazol pirazolopirimidinas como antagonistas de receptor de crf1. |
KR100854679B1 (ko) * | 2007-02-03 | 2008-08-27 | 김기형 | 심플 서비스 로케이션 프로토콜 네트워크 시스템 및 이를구성하는 에이전트. |
EP2282998B1 (en) * | 2008-04-21 | 2014-09-10 | Albemarle Corporation | Processes for producing n-alkylpyrazole |
EP2531490B1 (en) * | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
BR112015009751A2 (pt) | 2012-10-31 | 2017-07-11 | Bayer Cropscience Ag | novos compostos heterocíclicos como pesticidas |
ES2754590T3 (es) * | 2014-04-10 | 2020-04-20 | Hubei Bio Pharmaceutical Industrial Tech Institute Inc | An¿¢logos de compuestos de 4h-pirazolo[1,5-¿A]bencimidazol como inhibidores de las PARP |
KR20230092870A (ko) * | 2020-07-27 | 2023-06-26 | 에스팜 바이오테크 피티와이 엘티디 | 화합물 |
CN116322544A (zh) | 2020-08-12 | 2023-06-23 | 云杉生物科学公司 | 用于治疗***的方法和组合物 |
US11708372B2 (en) | 2021-11-19 | 2023-07-25 | Spruce Biosciences, Inc. | Crystalline composition of tildacerfont and methods of use and preparation thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1205009A (zh) * | 1996-02-07 | 1999-01-13 | 詹森药业有限公司 | 吡唑并嘧啶类化合物 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313124B1 (en) * | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
EA006626B1 (ru) | 1996-07-24 | 2006-02-24 | Дюпон Фармасьютикалз Компани | Азолопиримидины, фармацевтическая композиция и способ лечения |
HUP9903965A3 (en) | 1996-08-28 | 2002-02-28 | Pfizer | Substituted 6,5-hetero-bicyclic derivatives |
WO2000059908A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
EA200200421A1 (ru) | 1999-09-30 | 2002-10-31 | Ньюроджен Корпорейшн | АМИНОЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]-1,5-ПИРИМИДИНЫ И ПИРАЗОЛО[1,5-a]-1,3,5-ТРИАЗИНЫ |
CO5271670A1 (es) * | 1999-10-29 | 2003-04-30 | Pfizer Prod Inc | Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas |
ES2301633T3 (es) * | 2001-04-30 | 2008-07-01 | Glaxo Group Limited | Pirimidinas condensadas como antagonistas del factor de liberacion de corticotropina (crf). |
EP1395591B1 (en) * | 2001-06-12 | 2008-06-04 | Glaxo Group Limited | Corticotropin releasing factor antagonists |
GB0117396D0 (en) * | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
JP2006515334A (ja) * | 2003-01-16 | 2006-05-25 | エスビー ファームコ プエルト リコ インコーポレーテッド | CRF受容体アンタゴニストとしてのヘテロアリール置換ピロロ[2,3−b]ピリジン誘導体 |
EP1608652A1 (en) | 2003-03-31 | 2005-12-28 | Vernalis (Cambridge) Limited | Pyrazolopyrimidine compounds and their use in medicine |
US20070021429A1 (en) * | 2003-04-09 | 2007-01-25 | Yves St-Denis | Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
GB0308208D0 (en) * | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
EP1697369A1 (en) * | 2003-12-22 | 2006-09-06 | SB Pharmco Puerto Rico Inc | Crf receptor antagonists and methods relating thereto |
DE102004008807A1 (de) * | 2004-02-20 | 2005-09-08 | Bayer Cropscience Ag | Pyrazolopyrimidine |
GB0519957D0 (en) * | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
EP1802621B1 (en) * | 2004-10-19 | 2009-05-06 | SmithKline Beecham (Cork) Limited | Crf receptor antagonists and methods relating thereto |
US8088779B2 (en) * | 2005-09-30 | 2012-01-03 | Smithkline Beecham (Cork) Limited | Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
-
2004
- 2004-12-20 JP JP2006546391A patent/JP4926720B2/ja not_active Expired - Fee Related
- 2004-12-20 BR BRPI0417943-9A patent/BRPI0417943A/pt not_active Application Discontinuation
- 2004-12-20 NZ NZ547990A patent/NZ547990A/en unknown
- 2004-12-20 US US10/596,648 patent/US7737154B2/en active Active
- 2004-12-20 CN CN2004800420125A patent/CN1938309B/zh not_active Expired - Fee Related
- 2004-12-20 AR ARP040104790A patent/AR046967A1/es not_active Application Discontinuation
- 2004-12-20 TW TW093139578A patent/TW200530242A/zh unknown
- 2004-12-20 CA CA002550948A patent/CA2550948A1/en not_active Abandoned
- 2004-12-20 EP EP04820857A patent/EP1697374B1/en active Active
- 2004-12-20 KR KR1020067012368A patent/KR20070009537A/ko not_active Application Discontinuation
- 2004-12-20 RU RU2006126675/04A patent/RU2394035C2/ru not_active IP Right Cessation
- 2004-12-20 WO PCT/IB2004/004234 patent/WO2005063755A1/en active Application Filing
- 2004-12-20 AU AU2004309168A patent/AU2004309168B2/en not_active Ceased
- 2004-12-20 MY MYPI20045253A patent/MY143499A/en unknown
-
2006
- 2006-06-05 ZA ZA200604574A patent/ZA200604574B/en unknown
- 2006-06-15 IL IL176350A patent/IL176350A0/en unknown
- 2006-06-27 MA MA29147A patent/MA29984B1/fr unknown
- 2006-07-11 IS IS8526A patent/IS8526A/is unknown
- 2006-07-11 NO NO20063230A patent/NO20063230L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1205009A (zh) * | 1996-02-07 | 1999-01-13 | 詹森药业有限公司 | 吡唑并嘧啶类化合物 |
Also Published As
Publication number | Publication date |
---|---|
NZ547990A (en) | 2010-04-30 |
EP1697374B1 (en) | 2012-08-29 |
US7737154B2 (en) | 2010-06-15 |
JP4926720B2 (ja) | 2012-05-09 |
IS8526A (is) | 2006-07-11 |
US20070287705A1 (en) | 2007-12-13 |
RU2006126675A (ru) | 2008-01-27 |
NO20063230L (no) | 2006-09-12 |
KR20070009537A (ko) | 2007-01-18 |
TW200530242A (en) | 2005-09-16 |
ZA200604574B (en) | 2007-11-28 |
MY143499A (en) | 2011-05-31 |
EP1697374A1 (en) | 2006-09-06 |
AU2004309168B2 (en) | 2009-04-23 |
BRPI0417943A (pt) | 2007-04-17 |
MA29984B1 (fr) | 2008-12-01 |
IL176350A0 (en) | 2006-10-05 |
WO2005063755A1 (en) | 2005-07-14 |
RU2394035C2 (ru) | 2010-07-10 |
JP2007515472A (ja) | 2007-06-14 |
CN1938309A (zh) | 2007-03-28 |
AR046967A1 (es) | 2006-01-04 |
CA2550948A1 (en) | 2005-07-14 |
AU2004309168A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1938309B (zh) | Crf受体拮抗剂及其相关方法 | |
CN108137603B (zh) | 氮杂环丁烷衍生物、其制备方法及用途 | |
CN101952283B (zh) | 咪唑并[1,2-a]吡啶和咪唑并[1,2-b]哒嗪衍生物 | |
JP4901744B2 (ja) | 副腎皮質刺激ホルモン放出因子(crf)受容体アンタゴニストとして有用なピラゾロ[1,5−アルファ]ピリミジニル誘導体 | |
CN1934091B (zh) | 治疗神经变性障碍的咪唑化合物 | |
CN102971317B (zh) | 四氢-吡啶并-嘧啶衍生物 | |
CN102015716B (zh) | 用于治疗C-Met酪氨酸激酶介导的疾病的咪唑并[1,2-b]哒嗪衍生物 | |
CN103119035B (zh) | 杂环化合物和它们作为糖原合成酶激酶-3抑制剂的用途 | |
CN102388055B (zh) | 咪唑并[2,1-b][1,3,4]噻二唑衍生物 | |
CN101687866B (zh) | 用于治疗响应于血色素5-ht6受体调节的疾病的喹啉化合物 | |
KR101353268B1 (ko) | 세로토닌 수용체 모듈레이터로서의 피리미딘 화합물 | |
MXPA06002618A (es) | Antagonistas del factor de liberacion de corticotropina (crf) y compuestos heterobiciclicos. | |
CN104945420A (zh) | 作为pi3k抑制剂的嘧啶酮类 | |
CN101918408A (zh) | 作为磷酸二酯酶10的抑制剂的芳基和杂芳基稠合的咪唑并[1,5-a]吡嗪 | |
CN103476776B (zh) | 作为FAK/Pyk2抑制剂的2,4-二氨基-6,7-二氢-5H-吡咯并[2,3]嘧啶衍生物 | |
CN101119998A (zh) | 吡唑并[1,5-A]嘧啶腺苷A2a受体拮抗剂 | |
JP2019503389A (ja) | Pde1阻害剤 | |
JP2002507208A (ja) | Gaba−a受容体リガンドとしての三環ピラゾロ−ピリダジノン類似体 | |
CN109721600A (zh) | 一类含氮稠环化合物及其制备方法和用途 | |
JP2007515474A (ja) | Crf受容体アンタゴニストおよびそれらに関連する方法 | |
TWI305534B (en) | 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin)-4-yl)-imidazo[1,2,a]pyrimidin-5(1h)-one derivatives | |
CN102548995B (zh) | 杂环腙化合物以及它们治疗癌症和炎症的用途 | |
CN103153999A (zh) | 作为***素受体-1抑制剂的新化合物 | |
CN102884063A (zh) | 可用作trpm8受体调节剂的取代的氮杂双环咪唑衍生物 | |
JP2005500356A (ja) | ゴナドトロピン放出ホルモンレセプターアンタゴニスト |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SMITHKLINE. BICHMAN (CORK) CO., LTD.; APPLICANT Free format text: FORMER OWNER: SB PHARMCO INC.; APPLICANT Effective date: 20081031 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20081031 Address after: The Irish Village Applicant after: Smith Klein beer (Kirk) Co., Ltd. Co-applicant after: Neurocrine Biosciences Inc. Address before: San Juan Applicant before: SB drug Puerto Rico Co-applicant before: Neurocrine Biosciences Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111109 Termination date: 20131220 |